Evidence map›Paper›PMID 25864432›Full record

ArticleScientific reports2015

Defining minimum essential factors to derive highly pure human endothelial cells from iPS/ES cells in an animal substance-free system.

Yu-Ting Wu, I-Shing Yu, Kuen-Jer Tsai, Chien-Yu Shih, Shiaw-Min Hwang, Ih-Jen Su, Po-Min Chiang

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Yu-Ting WuInstitute of Clinical Medicine, National Cheng Kung University, Tainan, Taiwan, ROC.
I-Shing YuLaboratory Animal Center, College of Medicine, National Taiwan University, Taipei, Taiwan, ROC.
Kuen-Jer TsaiInstitute of Clinical Medicine, National Cheng Kung University, Tainan, Taiwan, ROC.
Chien-Yu ShihInstitute of Clinical Medicine, National Cheng Kung University, Tainan, Taiwan, ROC.
Shiaw-Min HwangFood Industry Research and Development Institute, Hsinchu, Taiwan, ROC.
Ih-Jen SuDivision of Infectious Diseases, National Health Research Institutes, Tainan, Taiwan, ROC.
Po-Min ChiangInstitute of Clinical Medicine, National Cheng Kung University, Tainan, Taiwan, ROC.
National Cheng Kung University · TWFood Industry Research and Development Institute · TWNational Health Research Institutes · TWNational Taiwan University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is desirable to obtain unlimited supplies of endothelial cells for research and therapeutics. However, current methods of deriving endothelial cells from humans suffer from issues, such as limited supplies, contamination from animal substances, and lengthy/complicated procedures. In this article we developed a way to differentiate human iPS and ES cells to highly pure endothelial cells in 5 days. The chemically defined system is robust, easy to perform, and free of animal substances. Using the system, we verified that combined TGFβ and canonical Wnt agonists are essential and sufficient for iPS/ES cell-to-mesoderm transition. Besides, VEGF-KDR signaling alone is required for endothelial formation at high density while supplementation with FGF allows for colonial endothelial differentiation. Finally, anti-adsorptive agents could enrich the endothelial output by allowing selective attachment of the endothelial precursors. The system was validated to work on multiple iPS/ES cells lines to produce endothelial cells capable of forming capillary-like structures in vitro and integrating into host vasculature in vivo. In sum, the simple yet robust differentiation system permits the unlimited supply of human endothelial cells. The defined and animal substance-free nature of the system is compatible with clinical applications and characterization of endothelial differentiation in an unbiased manner.

Indexed as

Cell DifferentiationAnimalsCell LineEmbryonic Stem CellsEndothelial CellsFibroblast Growth Factor 2Glycogen Synthase KinasesHumansInduced Pluripotent Stem CellsMesodermMiceTransforming Growth Factor betaVascular Endothelial Growth Factor Receptor-2Vascular Endothelial Growth FactorsWnt ProteinsFibroblast Growth Factor 2Glycogen Synthase KinasesTransforming Growth Factor betaVascular Endothelial Growth Factor Receptor-2Vascular Endothelial Growth FactorsWnt Proteins

Identifiers

PMID25864432
PMCPMC4394195
OpenAlexW2045150892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.